<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on April 28, 2026 at 6:20 AM by All in One SEO v4.9.6.2 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://cgxpwire.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>cGxP.wire</title>
		<link><![CDATA[https://cgxpwire.com]]></link>
		<description><![CDATA[cGxP.wire]]></description>
		<lastBuildDate><![CDATA[Tue, 28 Apr 2026 09:45:40 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://cgxpwire.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/scancell-advances-cancer-immunotherapy-pipeline-momentum/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/scancell-advances-cancer-immunotherapy-pipeline-momentum/]]></link>
			<title>Scancell Advances Cancer Immunotherapy Pipeline Momentum</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 09:45:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/mirai-bio-advances-targeted-lnp-delivery-at-asgct/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/mirai-bio-advances-targeted-lnp-delivery-at-asgct/]]></link>
			<title>Mirai Bio Advances Targeted LNP Delivery at ASGCT</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 09:26:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/sail-biomedicines-advances-in-vivo-erna-car-t-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/sail-biomedicines-advances-in-vivo-erna-car-t-data/]]></link>
			<title>Sail Biomedicines Advances In Vivo eRNA CAR-T Data</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 08:57:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/encoded-therapeutics-showcases-etx101-data-at-asgct/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/encoded-therapeutics-showcases-etx101-data-at-asgct/]]></link>
			<title>Encoded Therapeutics Showcases ETX101 Data at ASGCT</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 08:49:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/boehringer-survodutide-shows-16-6-weight-loss-in-phase-iii/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/boehringer-survodutide-shows-16-6-weight-loss-in-phase-iii/]]></link>
			<title>Boehringer Survodutide Shows 16.6% Weight Loss in Phase III</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 07:13:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/veterinary/elanco-secures-eua-for-screwworm-treatment-in-livestock/]]></guid>
			<link><![CDATA[https://cgxpwire.com/veterinary/elanco-secures-eua-for-screwworm-treatment-in-livestock/]]></link>
			<title>Elanco Secures EUA for Screwworm Treatment in Livestock</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 06:57:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/venture-capital-fund/fathom-therapeutics-raises-47m-to-advance-ai-drug-design/]]></guid>
			<link><![CDATA[https://cgxpwire.com/venture-capital-fund/fathom-therapeutics-raises-47m-to-advance-ai-drug-design/]]></link>
			<title>Fathom Therapeutics Raises $47M to Advance AI Drug Design</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 06:46:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/technology/ferrotec-introduces-ferrobeads-for-high-efficiency-dna-rna-isolation/]]></guid>
			<link><![CDATA[https://cgxpwire.com/technology/ferrotec-introduces-ferrobeads-for-high-efficiency-dna-rna-isolation/]]></link>
			<title>Ferrotec Introduces Ferrobeads for High-Efficiency DNA RNA Isolation</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 05:58:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/government/zentiva-appeals-eu-wastewater-directive-impact-on-pharma/]]></guid>
			<link><![CDATA[https://cgxpwire.com/government/zentiva-appeals-eu-wastewater-directive-impact-on-pharma/]]></link>
			<title>Zentiva Appeals EU Wastewater Directive Impact on Pharma</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 05:48:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/cellenkos-wins-fda-clearance-for-ck0801-phase-2-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/cellenkos-wins-fda-clearance-for-ck0801-phase-2-trial/]]></link>
			<title>Cellenkos Wins FDA Clearance for CK0801 Phase 2 Trial</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 05:38:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/galaxy-therapeutics-submits-pma-for-seal-device-fda/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/galaxy-therapeutics-submits-pma-for-seal-device-fda/]]></link>
			<title>Galaxy Therapeutics Submits PMA for SEAL Device FDA</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 05:29:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/johnson-johnson-strengthens-cns-portfolio-with-caplyta-fda-nod/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/johnson-johnson-strengthens-cns-portfolio-with-caplyta-fda-nod/]]></link>
			<title>Johnson &amp; Johnson Strengthens CNS Portfolio with CAPLYTA FDA Nod</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 05:15:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/apotex-secures-fda-approval-for-infuvite-pediatric-injection/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/apotex-secures-fda-approval-for-infuvite-pediatric-injection/]]></link>
			<title>Apotex Secures FDA Approval for Infuvite Pediatric Injection</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 05:09:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/tytocare-wins-fda-de-novo-for-ai-ent-diagnostics/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/tytocare-wins-fda-de-novo-for-ai-ent-diagnostics/]]></link>
			<title>TytoCare Wins FDA De Novo for AI ENT Diagnostics</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 05:04:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/dark-horse-consulting-group-partners-with-porton-advanced-for-iits/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/dark-horse-consulting-group-partners-with-porton-advanced-for-iits/]]></link>
			<title>Dark Horse Consulting Group Partners with Porton Advanced for IITs</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 04:30:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/astrazeneca-saphnelo-pen-gains-fda-approval-in-us/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/astrazeneca-saphnelo-pen-gains-fda-approval-in-us/]]></link>
			<title>AstraZeneca Saphnelo Pen Gains FDA Approval in US</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 03:58:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/eli-lilly-to-acquire-ajax-therapeutics-in-2-3b-oncology-deal/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/eli-lilly-to-acquire-ajax-therapeutics-in-2-3b-oncology-deal/]]></link>
			<title>Eli Lilly to Acquire Ajax Therapeutics in $2.3B Oncology Deal</title>
			<pubDate><![CDATA[Tue, 28 Apr 2026 03:54:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/santhera-pharmaceuticals-gains-eu-boost-for-agamree-expansion/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/santhera-pharmaceuticals-gains-eu-boost-for-agamree-expansion/]]></link>
			<title>Santhera Pharmaceuticals Gains EU Boost for AGAMREE Expansion</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 11:07:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/clinuvel-advances-vitiligo-phase-3-with-ema-support/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/clinuvel-advances-vitiligo-phase-3-with-ema-support/]]></link>
			<title>Clinuvel Advances Vitiligo Phase 3 with EMA Support</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 09:57:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/adagio-medical-reports-positive-vclas-results-for-vt/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/adagio-medical-reports-positive-vclas-results-for-vt/]]></link>
			<title>Adagio Medical Reports Positive vCLAS Results for VT</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 09:26:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/novartis-itvisma-gains-chmp-boost-for-sma-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/novartis-itvisma-gains-chmp-boost-for-sma-therapy/]]></link>
			<title>Novartis Itvisma Gains CHMP Boost for SMA Therapy</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 05:57:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/johnson-johnson-persigma-trial-advances-afib-care/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/johnson-johnson-persigma-trial-advances-afib-care/]]></link>
			<title>Johnson &amp; Johnson PERSIGMA Trial Advances AFib Care</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 05:53:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/briohealth-strengthens-medtech-pipeline-with-fda-approval/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/briohealth-strengthens-medtech-pipeline-with-fda-approval/]]></link>
			<title>BrioHealth Strengthens MedTech Pipeline with FDA Approval</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 05:43:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/cgbio-wins-fda-ide-for-novosis-putty-spine-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/cgbio-wins-fda-ide-for-novosis-putty-spine-trial/]]></link>
			<title>CGBIO Wins FDA IDE for NOVOSIS PUTTY Spine Trial</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 05:36:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/orthotrophix-tpx-100-shows-breakthrough-in-knee-oa-study/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/orthotrophix-tpx-100-shows-breakthrough-in-knee-oa-study/]]></link>
			<title>OrthoTrophix TPX-100 Shows Breakthrough in Knee OA Study</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 05:29:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/arrowhead-gains-chmp-nod-for-redemplo-in-rare-disease/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/arrowhead-gains-chmp-nod-for-redemplo-in-rare-disease/]]></link>
			<title>Arrowhead Gains CHMP Nod for REDEMPLO in Rare Disease</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 05:07:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/anaxiom-avos-device-shows-safe-early-obesity-results/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/anaxiom-avos-device-shows-safe-early-obesity-results/]]></link>
			<title>Anaxiom AVOS Device Shows Safe Early Obesity Results</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 07:24:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/abbott-showcases-afib-tech-breakthrough-at-hrs-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/abbott-showcases-afib-tech-breakthrough-at-hrs-2026/]]></link>
			<title>Abbott Showcases AFib Tech Breakthrough at HRS 2026</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 05:00:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/medtronic-affera-catheters-show-strong-hrs-2026-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/medtronic-affera-catheters-show-strong-hrs-2026-data/]]></link>
			<title>Medtronic Affera Catheters Show Strong HRS 2026 Data</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 04:50:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/telomir-acquires-teli-to-secure-global-telomir-1-rights/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/telomir-acquires-teli-to-secure-global-telomir-1-rights/]]></link>
			<title>Telomir Acquires TELI to Secure Global Telomir-1 Rights</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 07:13:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/cerapedics-expands-pearlmatrix-access-via-vizient-deal/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/cerapedics-expands-pearlmatrix-access-via-vizient-deal/]]></link>
			<title>Cerapedics Expands PearlMatrix Access via Vizient Deal</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 04:40:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/novartis-coartem-baby-wins-who-nod-for-infant-malaria/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/novartis-coartem-baby-wins-who-nod-for-infant-malaria/]]></link>
			<title>Novartis Coartem Baby Wins WHO Nod for Infant Malaria</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 08:49:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/ascletis-advances-asc30-phase-ii-trial-in-diabetes/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/ascletis-advances-asc30-phase-ii-trial-in-diabetes/]]></link>
			<title>Ascletis Advances ASC30 Phase II Trial in Diabetes</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 04:23:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/intellia-nears-phase-3-crispr-data-in-hae-breakthrough/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/intellia-nears-phase-3-crispr-data-in-hae-breakthrough/]]></link>
			<title>Intellia Nears Phase 3 CRISPR Data in HAE Breakthrough</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 04:14:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/amphista-targeted-glue-data-shows-tumor-regression/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/amphista-targeted-glue-data-shows-tumor-regression/]]></link>
			<title>Amphista Targeted Glue Data Shows Tumor Regression</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 08:44:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/johnson-johnson-imaavy-delivers-2-year-gmg-control/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/johnson-johnson-imaavy-delivers-2-year-gmg-control/]]></link>
			<title>Johnson &amp; Johnson IMAAVY Delivers 2-Year gMG Control</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 08:36:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/government/fda-fast-tracks-psychedelic-therapies-for-mental-illness/]]></guid>
			<link><![CDATA[https://cgxpwire.com/government/fda-fast-tracks-psychedelic-therapies-for-mental-illness/]]></link>
			<title>FDA Fast-Tracks Psychedelic Therapies for Mental Illness</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 08:32:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/wuxi-biologics-chengdu-plant-set-for-gmp-biologics-output/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/wuxi-biologics-chengdu-plant-set-for-gmp-biologics-output/]]></link>
			<title>WuXi Biologics Chengdu Plant Set for GMP Biologics Output</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 08:24:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/mabwell-9mw2821-advances-to-phase-iii-in-tnbc-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/mabwell-9mw2821-advances-to-phase-iii-in-tnbc-trial/]]></link>
			<title>Mabwell 9MW2821 Advances to Phase III in TNBC Trial</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 07:33:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/abbvie-1-4b-durham-campus-to-boost-us-drug-manufacturing/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/abbvie-1-4b-durham-campus-to-boost-us-drug-manufacturing/]]></link>
			<title>AbbVie $1.4B Durham Campus to Boost US Drug Manufacturing</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 07:06:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/haemonetics-vascade-mvp-xl-shows-superior-closure/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/haemonetics-vascade-mvp-xl-shows-superior-closure/]]></link>
			<title>Haemonetics VASCADE MVP XL Shows Superior Closure</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 07:02:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/sanofi-cenrifki-wins-eu-chmp-boost-for-progressive-ms/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/sanofi-cenrifki-wins-eu-chmp-boost-for-progressive-ms/]]></link>
			<title>Sanofi Cenrifki Wins EU CHMP Boost for Progressive MS</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 06:52:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/kyowa-kirin-kura-oncology-launch-ziftomenib-aml-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/kyowa-kirin-kura-oncology-launch-ziftomenib-aml-trial/]]></link>
			<title>Kyowa Kirin, Kura Oncology Launch Ziftomenib AML Trial</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 06:43:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/regeneron-otarmeni-gene-therapy-fda-hearing-breakthrough/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/regeneron-otarmeni-gene-therapy-fda-hearing-breakthrough/]]></link>
			<title>Regeneron Otarmeni Gene Therapy FDA Hearing Breakthrough</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 06:32:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/flex-vessel-prep-shows-strong-12-month-outcomes/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/flex-vessel-prep-shows-strong-12-month-outcomes/]]></link>
			<title>FLEX Vessel Prep Shows Strong 12-Month Outcomes</title>
			<pubDate><![CDATA[Sat, 25 Apr 2026 06:23:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/compass-therapeutics-nears-key-data-for-tovecimig-in-btc/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/compass-therapeutics-nears-key-data-for-tovecimig-in-btc/]]></link>
			<title>Compass Therapeutics Nears Key Data for Tovecimig in BTC</title>
			<pubDate><![CDATA[Mon, 27 Apr 2026 03:50:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/novo-nordisk-oral-semaglutide-shows-pediatric-breakthrough/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/novo-nordisk-oral-semaglutide-shows-pediatric-breakthrough/]]></link>
			<title>Novo Nordisk Oral Semaglutide Shows Pediatric Breakthrough</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 08:52:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/technology/merck-partners-with-google-cloud-for-1b-ai-platform/]]></guid>
			<link><![CDATA[https://cgxpwire.com/technology/merck-partners-with-google-cloud-for-1b-ai-platform/]]></link>
			<title>Merck Partners with Google Cloud for $1B AI Platform</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 08:36:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/regeneron-sanofi-secure-fda-approval-for-dupixent-in-pediatric-csu/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/regeneron-sanofi-secure-fda-approval-for-dupixent-in-pediatric-csu/]]></link>
			<title>Regeneron &amp; Sanofi Secure FDA Approval for Dupixent in Pediatric CSU</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 08:31:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/dogwood-therapeutics-secures-100m-partnership-for-antiviral-assets/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/dogwood-therapeutics-secures-100m-partnership-for-antiviral-assets/]]></link>
			<title>Dogwood Therapeutics Secures $100M Partnership for Antiviral Assets</title>
			<pubDate><![CDATA[Fri, 24 Apr 2026 08:23:39 +0000]]></pubDate>
		</item>
				</channel>
</rss>
